Previous Close | 3.88 |
1-Year Change | -51.44% |
6-Months Change | -51.01% |
3-Months Change | -23.02% |
Moving Avg (50d) | 4.4369 |
Moving Avg (200d) | 6.6192 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 316.9M |
Beta (3-Years) | 2 |
Revenue Growth (ttm) | -4.03% |
Net Profit Margin (ttm) | -792.7% |
Return On Assets (ttm) | -38.66% |
EPS (ttm) | -2.7 |
PE Ratio (ttm) | -1.44 |
Dividend Yield | % |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |